Detalhe da pesquisa
1.
Extensively Drug-Resistant Carbapenemase-Producing Pseudomonas aeruginosa and Medical Tourism from the United States to Mexico, 2018-2019.
Emerg Infect Dis
; 28(1): 51-61, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34932447
2.
Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial.
Ann Intern Med
; 167(10): 689-697, 2017 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29114781
3.
Notes from the Field: Verona Integron-Encoded Metallo-ß-Lactamase-Producing Carbapenem-Resistant Pseudomonas aeruginosa Infections in U.S. Residents Associated with Invasive Medical Procedures in Mexico, 2015-2018.
MMWR Morb Mortal Wkly Rep
; 68(20): 463-464, 2019 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31120867
4.
Zika Virus infection and Guillain-Barré syndrome in Northeastern Mexico: A case-control study.
PLoS One
; 15(3): e0230132, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32214354
5.
Seroprevalence of spotted fever group rickettsiae in canines along the United States-Mexico border.
Zoonoses Public Health
; 66(8): 918-926, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31441594
6.
Exposure to Latent Tuberculosis Treatment during Pregnancy. The PREVENT TB and the iAdhere Trials.
Ann Am Thorac Soc
; 15(5): 570-580, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29393655
7.
Tuberculosis contacts, concerns, and controls: what matters for healthcare workers?
Infect Control Hosp Epidemiol
; 27(5): 433-5, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16671021
8.
Justifying research risks in a clinical trial for treatment of multidrug-resistant tuberculosis.
IRB
; 33(4): 10-7, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21932482
9.
Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention.
MMWR Recomm Rep
; 52(RR-2): 15-8, 2003 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-12583541
10.
Back to the future: where now for antituberculosis drugs?
Enferm Infecc Microbiol Clin
; 24(2): 69-70, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16545311
11.
Back to the Future: Where Now for Antituberculosis Drugs?
Enferm. infecc. microbiol. clín. (Ed. impr.)
; 24(2): 69-70, feb. 2006.
Artigo
em En
| IBECS (Espanha) | ID: ibc-043732
12.
Tuberculosis in Low Incidence Areas: Where are the Resources for Control or Elimination?
Enferm. emerg
; 8(4): 239-242, oct.-dic. 2006.
Artigo
em Inglês
| IBECS (Espanha) | ID: ibc-111184